In the present study, female sex in PD with LRRK2 G2385R non-carriers had milder severity in motor symptoms and lower risk in EDS, autonomic dysfunction and SN hyperechogenicity but higher risk in mood disorders, which is in agreement with most published data [3, 10, 23–25]. This evidence concerns the gene LRRK2 and Parkinson disease.